Persistence Market Research forecasts the global bile duct cancer treatment market to grow from about US$ 168 Mn in 2017 to about US$ 312 Mn by 2025 end. This represents a CAGR of 8% over the forecast period 2017 – 2025. The global bile duct cancer treatment market represents absolute dollar opportunity of US$ 12.5 Mn in 2018 over 2017 and incremental opportunity of US$ 144.2 Mn between 2017 and 2025.

Cancer is the leading cause of death worldwide, and the proportion of cancer deaths around the world increased from 12% in 1990 to 15% in 2015. According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths each year, with 70% new cancer cases expected to be reported over the next 20 years. Incidence of liver cancer and bile duct cancer in North America has increased dramatically in the past few years. According to the cholangiocarcinoma foundation, about 6,000 people suffer from bile duct cancer every year in the United States. In the U.S, the average age of people diagnosed with cancer is between 70 and 75.

Request A Sample Report@ https://www.persistencemarketresearch.com/samples/10094

Bile duct cancer is highest among Asians and Hispanics as compared to non-Hispanic whites and blacks. The mortality rate in men is slightly higher than women suffering from bile duct cancer. The incidence rate of cholangiocarcinoma in Canada is 0.35 per 100,000 population and the number of cases are likely to increase due to a sedentary lifestyle, exposure to chemicals, and bile duct infections. Each cancer type requires advanced treatments. An increasing prevalence of cancer and the need for combination therapies is expected to increase the demand for chemotherapy – based treatments as a first line of therapy. This is likely to provide significant opportunities for players to conduct clinical trials to establish the therapeutic efficacy and launch their products in this market.

Summary of Table of Content

1. Executive Summary

2. Market Introduction

3. Market View Point

4. North America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Analysis 2012–2016 and Forecast 2017–2025

5. Latin America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Analysis and Forecast, 2015-2015, By Products

6. Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Analysis and Forecast

7. Asia Pacific Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Analysis and Forecast

8. MEA Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Analysis and Forecast

9. Competition Landscape

10. Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Region

11. Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Treatment Type

12. Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Disease Indication

13. Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Distribution Channel

14. Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Analysis, By Services Spending

15. Global Market Analysis 2012–2016 and Forecast 2017–2025

Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/market-research/bile-duct-cancer-treatment-market/toc